5. Conclusions
asthma
DISEASE, ASTHMA
Our study significantly shows the role of clinical pharmacist-led intervention in enhancing medication adherence in asthma patients, increasing treatment efficacy, relieving symptom severity, and reducing the medication burden from the disease. Risk factors related to medication adherence, such as pharmacist-led intervention, in the age group >60 had an increased adherence rate. In addition, the COVID-19 pandemic had a major impact and significantly reduced the adherence. These data could be the basis for policy reforms to improve the adherence rate. In addition, medication adherence intervention should emphasize young patients and those with limited mobility (such as preventing medical examination due to the COVID-19 pandemic). Therefore, the intervention will be beneficial for every healthcare practitioner to apply if strictly following the education and counseling content.